# Treatment of an Inherited Ventricular Arrhythmia

> **NCT05122975** · PHASE2 · TERMINATED · sponsor: **RyCarma Therapeutics, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Catecholaminergic Polymorphic Ventricular Tachycardia Type 1

## Interventions

- **DRUG:** S48168 (ARM210)
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT05122975
- **Lead sponsor:** RyCarma Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-08-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Due to challenges in recruiting patients.
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05122975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05122975, "Treatment of an Inherited Ventricular Arrhythmia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05122975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*